KBC Group
MBII

KBC Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

KBC Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-119,018
Closed -$248K – 1332
2021
Q1 		$248K Buy
+119,018
New +$247K ﹤0.01% 1155

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

KBC Group's MBII Position: Q2 2021 in Review

KBC Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2021, closing a stake of 119,018 shares — an estimated $248K sold.

KBC Group first reported a position in MBII in Q1 2021 and held it in 1 quarter. The position peaked at $248K in Q1 2021. 72 funds tracked by Wall St. Rank hold MBII as of Q2 2021.

  • KBC Group reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2021 after selling out during the quarter.
  • KBC Group sold 119,018 Marrone Bio Innovations, Inc. shares in Q2 2021, an estimated $248K.
  • KBC Group first reported a position in Marrone Bio Innovations, Inc. in Q1 2021 and held it in 1 quarter.
  • KBC Group's Marrone Bio Innovations, Inc. position peaked at $248K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2021.

Based on KBC Group's 13F filing for Q2 2021, filed 11 Aug 2021.